<DOC>
	<DOCNO>NCT00563160</DOCNO>
	<brief_summary>To study activity chemotherapy Gemzar-carboplatin preoperative setting operable stage non-small-cell lung cancer identify novel molecular marker correlate chemosensitivity prognosis</brief_summary>
	<brief_title>Study Efficacy Induction Chemotherapy With Gemcitabine Carboplatin Operable Non-small-cell Lung Cancer Before Surgery</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically cytologically proven , newly diagnose primary bronchogenic nonsmall cell lung cancer Measurable evaluable tumour chest Xray CT scan . No multiple ipsilateral contralateral parenchymal tumour Stage I ( exceptT1N0 ) , II , IIIa disease show PETCT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>lung cancer</keyword>
</DOC>